Ménard, S <br/><br/>
No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomas.  [electronic resource] 

 -  Journal of the National Cancer Institute  Jul 1996 
 - 1002-3 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0027-8874 
<br/><br/><label>Standard No.: </label>10.1093/jnci/88.14.1002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>Female<br/>Genes, erbB-2--genetics<br/>Genes, p53--genetics<br/>Humans<br/>Immunohistochemistry<br/>Lymphatic Metastasis<br/>Mutation<br/>Neoplasm Staging<br/>Receptor, ErbB-2--genetics<br/>Survival Analysis<br/>Tumor Suppressor Protein p53--genetics